SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,439,000 | +10.7% | 307,087 | +8.7% | 0.00% | 0.0% |
| Q2 2017 | $3,107,000 | +9.5% | 282,402 | -2.5% | 0.00% | +100.0% |
| Q1 2017 | $2,838,000 | -4.9% | 289,617 | +4.9% | 0.00% | -50.0% |
| Q4 2016 | $2,983,000 | +17.9% | 276,147 | +11.9% | 0.00% | +100.0% |
| Q3 2016 | $2,531,000 | -19.1% | 246,885 | +3.0% | 0.00% | -50.0% |
| Q2 2016 | $3,130,000 | +44614.3% | 239,635 | +26885.9% | 0.00% | – |
| Q3 2014 | $7,000 | +75.0% | 888 | +20.0% | 0.00% | – |
| Q2 2014 | $4,000 | -94.8% | 740 | -95.6% | 0.00% | – |
| Q1 2014 | $77,000 | -70.9% | 16,800 | -68.1% | 0.00% | – |
| Q4 2013 | $265,000 | -35.7% | 52,640 | -35.3% | 0.00% | – |
| Q3 2013 | $412,000 | +2.5% | 81,301 | +0.3% | 0.00% | – |
| Q2 2013 | $402,000 | – | 81,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|